Nalaganje...
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox–Gastaut syndrome
Clobazam is the newest medication approved by the US Food and Drug Administration (FDA) for the treatment of Lennox–Gastaut syndrome (LGS) in patients at least 2 years of age, although the medication has been available in countries around the world to treat epilepsy and anxiety disorders for many ye...
Shranjeno v:
| izdano v: | Ther Clin Risk Manag |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4467745/ https://ncbi.nlm.nih.gov/pubmed/26089675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S55930 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|